(Q41386331)

30 September 2017

1 reference

title

Estrogens, menopause, and coronary artery disease (English)

1 reference

30 September 2017

1 reference

Sullivan JM

1

1 reference

30 September 2017

Fowlkes LP

series ordinal

2

1 reference

30 September 2017

language of work or name

1 reference

1 February 1996

1 reference

30 September 2017

1 reference

30 September 2017

volume

14

1 reference

30 September 2017

issue

1

1 reference

30 September 2017

page(s)

105-116

1 reference

High density lipoprotein cholesterol, total cholesterol screening, and myocardial infarction. The Framingham Study

30 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970264-2

7 January 2021

Inhibition of coronary artery atherosclerosis by 17-beta estradiol in ovariectomized monkeys. Lack of an effect of added progesterone

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970264-2

7 January 2021

Use of postmenopausal hormones and risk of myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970264-2

7 January 2021

Incidence of cardiovascular disease and death in patients receiving diethylstilbestrol for carcinoma of the prostate

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970264-2

7 January 2021

Cardiovascular mortality and noncontraceptive use of estrogen in women: results from the Lipid Research Clinics Program Follow-up Study

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970264-2

7 January 2021

Hormone replacement therapy and risk of breast cancer: results from epidemiologic studies

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970264-2

7 January 2021

Benefits and risks of menopausal estrogen and/or progestin hormone use.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970264-2

7 January 2021

Decreased risk of stroke among postmenopausal hormone users. Results from a national cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970264-2

7 January 2021

Experimental atherosclerosis: effects of oestrogen and atherosclerosis on thromboxane and prostacyclin formation

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970264-2

7 January 2021

The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970264-2

7 January 2021

Effects of physiological levels of estrogen on coronary vasomotor function in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970264-2

7 January 2021

Uncertainty about postmenopausal estrogen. Time for action, not debate

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970264-2

7 January 2021

Hormone therapy to prevent disease and prolong life in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970264-2

7 January 2021

Postmenopausal use of estrogen and occlusion of coronary arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970264-2

7 January 2021

Relationship of plasma lipoprotein Lp(a) levels to race and to apolipoprotein B.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970264-2

7 January 2021

Estrogen replacement therapy and protection from acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970264-2

7 January 2021

Hormonal regulation of serum Lp (a) levels. Opposite effects after estrogen treatment and orchidectomy in males with prostatic carcinoma

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970264-2

7 January 2021

Endothelial-dependent coronary vasomotor responsiveness in postmenopausal women with and without estrogen replacement therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970264-2

7 January 2021

Effects of estrogen replacement therapy on serum lipid values and angiographically defined coronary artery disease in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970264-2

7 January 2021

Noncontraceptive estrogens and nonfatal myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970264-2

7 January 2021

Metabolic risk factors for coronary heart disease in women: perspective from the Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970264-2

7 January 2021

Patterns of coronary heart disease morbidity and mortality in the sexes: a 26-year follow-up of the Framingham population

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970264-2

7 January 2021

Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970264-2

7 January 2021

Risk factors and noncontraceptive estrogen use in women with and without coronary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970264-2

7 January 2021

Association of hormone-replacement therapy with various cardiovascular risk factors in postmenopausal women. The Atherosclerosis Risk in Communities Study Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970264-2

7 January 2021

Estrogen Replacement Therapy II: A Prospective Study in the Relationship to Carcinoma and Cardiovascular and Metabolic Problems

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970264-2

7 January 2021

Coronary risk and estrogen use in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970264-2

7 January 2021

Estrogen-induced regression of coronary atherosclerosis in cholesterol-fed chicks

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970264-2

7 January 2021

Ethinyl estradiol acutely attenuates abnormal coronary vasomotor responses to acetylcholine in postmenopausal women.

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970264-2

7 January 2021

Menopausal oestrogen therapy and protection from death from ischaemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970264-2

7 January 2021

Plasma Lp(a) concentration after oestrogen and progestagen in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970264-2

7 January 2021

Estrogen replacement therapy and coronary heart disease: a quantitative assessment of the epidemiologic evidence

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970264-2

7 January 2021

Postmenopausal estrogen therapy and cardiovascular disease. Ten-year follow-up from the nurses' health study

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970264-2

7 January 2021

A prospective study of postmenopausal estrogen therapy and coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970264-2

7 January 2021

A Meta-analysis of the Effect of Estrogen Replacement Therapy on the Risk of Breast Cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970264-2

7 January 2021

Estrogen replacement and coronary artery disease. Effect on survival in postmenopausal women

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970264-2

7 January 2021

Postmenopausal estrogen use and coronary atherosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970264-2

7 January 2021

Estrogen modulates responses of atherosclerotic coronary arteries

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970264-2

7 January 2021

Postmenopausal estrogen use, cigarette smoking, and cardiovascular morbidity in women over 50. The Framingham Study

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970264-2

7 January 2021

Reduction of cardiovascular disease-related mortality among postmenopausal women who use hormones: evidence from a national cohort

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970264-2

7 January 2021

The degree of coronary atherosclerosis in bilaterally oophorectomized women

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970264-2

7 January 2021

Serum prostacyclin stabilizing factor is identical to apolipoprotein A-I (Apo A-I). A novel function of Apo A-I

1 reference

https://api.crossref.org/works/10.1016%2FS0733-8651%2805%2970264-2

7 January 2021

10.1016/S0733-8651(05)70264-2

Identifiers

DOI

1 reference

30 September 2017

1 reference